[HTML][HTML] NODDI in clinical research

K Kamiya, M Hori, S Aoki - Journal of neuroscience methods, 2020 - Elsevier
Diffusion MRI (dMRI) has proven to be a useful imaging approach for both clinical diagnosis
and research investigating the microstructures of nervous tissues, and it has helped us to …

Systematic review: quantitative susceptibility map** (QSM) of brain iron profile in neurodegenerative diseases

P Ravanfar, SM Loi, WT Syeda… - Frontiers in …, 2021 - frontiersin.org
Iron has been increasingly implicated in the pathology of neurodegenerative diseases. In
the past decade, development of the new magnetic resonance imaging technique …

CuII(atsm) inhibits ferroptosis: Implications for treatment of neurodegenerative disease

A Southon, K Szostak, KM Acevedo… - British journal of …, 2020 - Wiley Online Library
Background and Purpose Diacetyl‐bis (4‐methyl‐3‐thiosemicarbazonato) copperII (CuII
(atsm)) ameliorates neurodegeneration and delays disease progression in mouse models of …

MRI biomarkers for memory-related impairment in amyotrophic lateral sclerosis: a systematic review

S Ghaderi, F Fatehi, S Kalra… - … Lateral Sclerosis and …, 2023 - Taylor & Francis
Introduction Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder associated
with cognitive and behavioral impairments and motor symptoms. Magnetic resonance …

Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS

NA Goyal, JD Berry, A Windebank, NP Staff… - Muscle & …, 2020 - Wiley Online Library
Amyotrophic lateral sclerosis (ALS) is a debilitating neurodegenerative disorder with
complex biology and significant clinical heterogeneity. Many preclinical and early phase …

Diagnostics of amyotrophic lateral sclerosis: up to date

I Štětkářová, E Ehler - Diagnostics, 2021 - mdpi.com
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease
characterized by gradual loss of upper and lower motor neurons and their pathways, usually …

Tracking a fast-moving disease: longitudinal markers, monitoring, and clinical trial endpoints in ALS

RH Chipika, E Finegan, S Li Hi Shing… - Frontiers in …, 2019 - frontiersin.org
Amyotrophic lateral sclerosis (ALS) encompasses a heterogeneous group of phenotypes
with different progression rates, varying degree of extra-motor involvement and divergent …

Survival prediction in Amyotrophic lateral sclerosis based on MRI measures and clinical characteristics

C Schuster, O Hardiman, P Bede - BMC neurology, 2017 - Springer
Background Amyotrophic lateral sclerosis (ALS) a highly heterogeneous neurodegenerative
condition. Accurate diagnostic, monitoring and prognostic biomarkers are urgently needed …

Focus on the heterogeneity of amyotrophic lateral sclerosis

C Bendotti, V Bonetto, E Pupillo… - … Lateral Sclerosis and …, 2020 - Taylor & Francis
The clinical manifestations of amyotrophic lateral sclerosis (ALS) are variable in terms of age
at disease onset, site of onset, progression of symptoms, motor neuron involvement, and the …

Structural magnetic resonance imaging findings and histopathological correlations in motor neuron diseases—A systematic review and meta-analysis

C Zejlon, D Nakhostin, S Winklhofer, A Pangalu… - Frontiers in …, 2022 - frontiersin.org
Objectives The lack of systematic evidence on neuroimaging findings in motor neuron
diseases (MND) hampers the diagnostic utility of magnetic resonance imaging (MRI). Thus …